在结直肠恶性瘤中使用PARP抑制剂:2023年更新
Nikolaos Skouteris1, Georgios Papageorgiou2
1Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, "Metaxa" Cancer Hospital, 51 Botassi Street, 18537 Piraeus, Greece.
Reviews on recent clinical trials
|December 7, 2023
概括
聚 (ADP-ribose) 聚合酶 (PARP) 抑制剂对转移性结直肠癌 (CRC) 具有DNA损伤修复 (DDR) 改变有前景. 需要进一步的研究来建立这些向治疗的正式指示.
科学领域:
- 在瘤学瘤学.
- 医学遗传学 医学遗传学
- 药理学 药理学是指药理学的学科.
背景情况:
- 大肠直肠癌 (CRC) 是一种普遍存在的恶性瘤,在转移阶段的预后不佳.
- 在CRC中,DNA损伤修复 (DDR) 途径的改变是常见的,具有治疗脆弱性.
- 聚 (ADP-ribose) 聚合酶 (PARP) 抑制剂在缺乏DDR的癌症中利用合成致死性.
研究的目的:
- 审查PARP抑制剂在转移性CRC患者中具有DDR路径改变的作用.
- 评估PARP抑制剂作为单独或组合治疗的治疗选择.
主要方法:
- 在PubMed数据库的系统文献搜索.
- 包括在转移性CRC与同源修复缺陷 (HRD) 中证明PARP抑制剂有效性的人类研究.
主要成果:
- 目前的证据表明,PARP抑制剂在特定的CRC亚组中是有益的.
- PARP 抑制剂显示出作为单一治疗和与其他治疗结合的潜力.
结论:
- 数据正在出现,支持在精选的CRC患者中使用PARP抑制剂.
- 需要进一步的研究来确定正式的适应症和优化治疗策略.
- 识别具有同源修复缺陷 (HRD) 的患者对于向治疗至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K